Influence of recombinant asparaginase treatment on laboratory parameters (mean ± SD)
| Parameter . | Normal value . | Baseline (< day 1) . | Week 1 (days 1-11) . | Week 2 (days 12-17) . | Week 3 (days 18-23) . | Week 4 (days 24-32) . | Day 33 . |
|---|---|---|---|---|---|---|---|
| Bilirubin (μmol/L) | < 17 | 7.8 ± 3.9 | 9.1 ± 5.2 | 14.9 ± 6.5 | 16.9 ± 7.1 | 21.7 ± 14.1 | 29.4 ± 16.3 |
| SGOT (U/L) | < 56 | 37 ± 25 | 138 ± 235 | 75 ± 141 | 30 ± 23 | 28 ± 14 | 40 ± 22 |
| SGPT (U/L) | < 39 | 23 ± 29 | 284 ± 514 | 222 ± 333 | 98 ± 105 | 82 ± 54 | 80 ± 37 |
| Creatinine (μmol/L) | 18-88 | 38 ± 21 | 32 ± 15 | 29 ± 13 | 29 ± 15 | 29 ± 11 | 26 ± 13 |
| Parameter . | Normal value . | Baseline (< day 1) . | Week 1 (days 1-11) . | Week 2 (days 12-17) . | Week 3 (days 18-23) . | Week 4 (days 24-32) . | Day 33 . |
|---|---|---|---|---|---|---|---|
| Bilirubin (μmol/L) | < 17 | 7.8 ± 3.9 | 9.1 ± 5.2 | 14.9 ± 6.5 | 16.9 ± 7.1 | 21.7 ± 14.1 | 29.4 ± 16.3 |
| SGOT (U/L) | < 56 | 37 ± 25 | 138 ± 235 | 75 ± 141 | 30 ± 23 | 28 ± 14 | 40 ± 22 |
| SGPT (U/L) | < 39 | 23 ± 29 | 284 ± 514 | 222 ± 333 | 98 ± 105 | 82 ± 54 | 80 ± 37 |
| Creatinine (μmol/L) | 18-88 | 38 ± 21 | 32 ± 15 | 29 ± 13 | 29 ± 15 | 29 ± 11 | 26 ± 13 |